← Back to patent-cliff list
CAS 2536-53-0
N-[4-(2-Amino-4-oxo-1,4-dihydropteridin-6-ylmethylamino)-3,5-dibromobenzoyl]-L-glutamic acid
Codes：Folic Acid-026
Application context (from source-drug indications)
原发性高血压马来酸依那普利/叶酸巨幼红细胞性贫血叶酸叶酸缺乏叶酸神经管缺损叶酸贫血叶酸热潮红叶酸高同型半胱氨酸血症叶酸
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Enalapril Maleate/Folic AcidEnalapril Maleate/Folic Acid | Tier C — Watch / trade | - |
| Folic AcidFolic Acid | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
N-[4-(2-Amino-4-oxo-1,4-dihydropteridin-6-ylmethylamino)-3,5-dibromobenzoyl]-L-glutamic acid→N-[4-(2-Amino-4-oxo-1,4-dihydropteridin-6-ylmethylamino)-3,5-dideuterobenzoyl]-L-glutamic acid
N-[4-(2-Amino-4-oxo-1,4-dihydropteridin-6-ylmethylamino)-3,5-dibromobenzoyl]-L-glutamic acid→N-[4-(2-Amino-4-oxo-1,4-dihydropteridin-6-ylmethylamino)-3,5-dideuterobenzoyl]-L-glutamic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.